Canada approves Bovaer® as first feed ingredient to reduce methane emissions from cattle

The Canadian authorities today granted market authorization for Bovaer®, a methane reducing feed ingredient for cattle, which enables dairy and beef farmers to substantially lower their carbon footprint.

Kaiseraugst (Switzerland), January 30th, 2024

dsm-firmenich, the leading innovator in nutrition, health and beauty, today received market authorization for Bovaer® in Canada for use with dairy and beef cattle.  Bovaer® is a feed ingredient which immediately and effectively reduces methane emissions from cattle.

This feed ingredient is an important tool for the nearly 10,000 dairy farmers in Canada, and will enable them to make a substantial step forward towards their net zero ambitions. Bovaer® reduces methane emissions by 30% on average for dairy cows, and thereby lowers the overall greenhouse gas footprint per liter of milk by 10-15%.

Likewise, Canadian cattle feeders can reduce methane emissions by 45% on average for the 3.3 million cattle they manage annually. Once Bovaer® is included in the Reducing Enteric Methane Emissions (REME) protocol for beef cattle and the Alberta Fed Cattle protocol, cattle feeders will also be able to generate carbon offsets as an additional source of income.

“Canada has been an important part of the development journey of Bovaer®.  In 2020, dsm-firmenich successfully completed the longest and largest trial with Bovaer®, a two-year trial with 15,000 beef cattle in Alberta and supported by ERA (Emission Reduction Alberta), which demonstrated methane reductions of up to 82%, resulting in savings of 1,473 tons of CO2e during this study alone. We are therefore excited today to receive the market authorization and appreciate the diligent and timely review by the Canadian Food Inspection Agency” says Mark van Nieuwland, Vice President Bovaer®.  “This will benefit Canadian farmers, sustainability efforts of the sector, and support Canada in delivering on its international emissions reduction commitments such as the Global Methane Pledge”.

dsm-firmenich aims to make Bovaer® available to the Canadian dairy and beef sector in the upcoming weeks, and will work closely with the feed, dairy and beef sector to introduce Bovaer® in the market.

About Bovaer®

Bovaer® is a feed ingredient for cows and cattle (and other ruminants, such as sheep, goats, and deer) researched and developed over the last 10 years. Just a quarter teaspoon of Bovaer® per cow per day consistently reduces enteric methane emission by on average 30% for dairy cows and even higher percentages, on average 45%, for feedlot beef cattle. The feed ingredient Bovaer® therefore contributes to a significant and immediate reduction of the environmental footprint of dairy and beef products. Bovaer® is now commercially available in 58 countries, and has been tested in over 65 farm trials, across 20 countries, resulting in over 70 peer reviewed scientific publications.


About dsm-firmenich 

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.


For more information

Bovaer Website



Patrick Weiss, Head of Communications Animal Nutrition & Health                       

Forward-looking statements

This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language

Published on

30 January 2024



You are being redirected.

We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.